Viewing Study NCT02592356


Ignite Creation Date: 2025-12-24 @ 11:34 PM
Ignite Modification Date: 2026-02-25 @ 8:27 PM
Study NCT ID: NCT02592356
Status: COMPLETED
Last Update Posted: 2024-03-05
First Post: 2015-10-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Differentiated Thyroid Gland Carcinoma View
None Malignant Adrenal Gland Pheochromocytoma View
None Malignant Paraganglioma View
None Thyroid Gland Medullary Carcinoma View
Keywords: